Investigators assessed the use of different combined oral contraceptive pills for the treatment and management of polycystic ovary syndrome, as an update to recent evidence-based guidelines.
Once thought to be rare, the prevalence of primary aldosteronism is estimated to be 5% to 17%, although the condition remains underdiagnosed.
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults.
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
A 14-year-old adolescent with epilepsy presents with increasing episodes of nosebleeds, increased rate of speech, leg pain with little exercise, and irritable mood. Learn how delayed diagnosis of Graves disease affected her treatment.
Researchers assessed the relationship between fasting blood glucose levels and the risk of mortality in patients hospitalized with COVID-19.
Author reviews the pathophysiology of obesity including the role of incretin hormones and the mechanism of action, efficacy, and safety of GLP-1 receptor agonists as antiobesity medications.
Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.
COVID-19 can cause additional complications and even death in people with a pre-existing conditions like type 2 diabetes. Researchers studied whether the medications people with type 2 diabetes often take were associated with a risk of dying from the virus.
